<DOC>
	<DOCNO>NCT01778322</DOCNO>
	<brief_summary>The objective clinical study evaluate clinical utility WEB Aneurysm Embolization System use embolize intracranial aneurysm</brief_summary>
	<brief_title>WEB Clinical Assessment IntraSaccular Aneurysm Therapy</brief_title>
	<detailed_description>The following parameter evaluate part study : - Aneurysm morphology - Aneurysm size - For ruptured aneurysm : Hunt Hess Classification Subarachnoid Hemorrhage ( SAH ) - Size embolization device ( ) use procedure - Intra-procedural assessment aneurysm occlusion flow stasis - Degree aneurysm occlusion post-procedure ( percentage occlusion , Raymond Scale score appropriate ) - Aneurysm occlusion durability - Recanalization rate - Device-related change Modified Rankin Scale baseline - Complications/adverse event - Rebleed/new bleed</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Must least 18 year age Must sign date IRB/ECapproved write informed consent prior initiation study procedure Must clinical angiographic evidence vasospasm Must lesion characteristic unsuitable endovascular treatment Must neurologic psychiatric condition , preclude ability comply aspect screen , evaluation , treatment , postprocedure followup schedule Must concurrently involve another investigational postmarket study Must receive investigational device treatment target intracranial aneurysm prior entry trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>